Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Nuvectra to Participate in Two Upcoming Investor Conferences


Posted on: 05 Sep 18

PLANO, Texas, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to participate in two upcoming investor conferences.

 Event:Morgan Stanley 16th Annual Global Healthcare Conference
 Date:Wednesday, September 12, 2018  
 Location:The Grand Hyatt, New York 
 Format:1x1 Meetings 
 
 Event:Cantor Fitzgerald Global Healthcare Conference 
 Date:Monday, October 1, 2018 
 Time4:40 p.m. ET 
 Location:InterContinental New York Barclay Hotel, New York
 Format:Presentation & 1x1 Meetings 


A webcast of the Company’s presentation at the Cantor Fitzgerald Global Healthcare Conference will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days.

About Nuvectra Corporation

NuvectraTM is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.

Company Contacts:            
Nuvectra Corporation         

Walter Berger, COO & CFO
(214) 474-3102                      
wberger@nuvectramed.com     

Investor Contacts:
The Ruth Group                  

Tram Bui / Brian Johnston
(646) 536-7035 / 7028           
investors@nuvectramed.com           

GlobeNewswire
globenewswire.com

Last updated on: 06/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.